doi:10.1016/j.cbi.2016.08.016 102
Betting on a widespread GLP-1 adoption, some private equity investors are practicing an investor version of the Ozempic diet and are refraining from investing in consumer companies (such as snackmakers, alcohol brands, or restaurant chains) that could be negatively impacted by the GLP-1 boom, believing that profits will get squeezed as GLP-1 users no longer crave them and/or obesity rates fall
And once starting the medications, it is equally vital to have regular check ins with your provider, and complete updated information forms when re-ordering each month - rolling subscriptions and an Amazon-esque style of ordering should be red flags when it comes to weight loss medications where your statistics and experience can mean the difference between continuing usage or discontinuing the medications
Gao X, Hua X, Wang X (2022) Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
Las fibras fermentables (avena, legumbres, alcachofas, semillas de cha), protenas de alta calidad (suero de leche, pescado, huevos) y grasas saludables (pescados grasos, aguacate, nueces) han demostrado estimular la secrecin de GLP-1 en estudios clnicos
